Involuntary Medication Orders: Treating Psychiatrist Testimony May Satisfy “Narrowly Tailored” Requirement Under Rivers v Katz

1. Introduction

Matter: Matter of Walawender v Antonio T., 2025 NY Slip Op 01516 (App Div, 4th Dept Mar. 14, 2025).
Parties: Petitioner-respondent Kara Walawender (Unit Chief, Central New York Psychiatric Center, Auburn Correctional Facility Satellite Unit) sought authorization to medicate respondent-appellant Antonio T. over objection.
Setting: Respondent was an involuntary patient at a psychiatric center.

The case addresses when the State may administer antipsychotic medication over an involuntary patient’s objection under New York’s parens patriae authority, and—critically—what proof suffices to show the proposed regimen is “narrowly tailored” to respect the patient’s liberty interests under Rivers v Katz.

2. Summary of the Opinion

The Fourth Department affirmed the order granting petitioner authorization to administer antipsychotic medication over respondent’s objection.

The order authorized a regimen including Abilify Maintena (up to 400 mg by intramuscular injection every three weeks or less) and Benadryl as needed for side effects, plus authorization for specified alternative antipsychotic medications and alternative side-effect medications.

The majority held petitioner proved by clear and convincing evidence both that (1) respondent lacked the capacity to make a reasoned treatment decision and (2) the two-year plan was narrowly tailored to give substantive effect to respondent’s liberty interest.

Dissent (Ogden, J.): agreed incapacity was proven, but would reverse because petitioner’s proof was legally insufficient to establish narrow tailoring—particularly given the absence of medical records in evidence, unclear justification for medication choice and dosage/frequency, and conclusory testimony about side-effect management and alternatives.

3. Analysis

A. Precedents Cited

Rivers v Katz, 67 NY2d 485 (1986), rearg denied 68 NY2d 808 (1986)

Rivers v Katz is the constitutional and doctrinal foundation for involuntary medication in New York. It requires:

  • Incapacity: proof the patient lacks capacity to make a reasoned decision regarding the proposed treatment; and
  • Narrow tailoring: proof the proposed plan is “narrowly tailored to give substantive effect to [the patient’s] liberty interest,” considering best interests, benefits, side effects, and less intrusive alternatives.

The majority applied Rivers directly, finding both prongs met. The dissent also applied Rivers but emphasized that narrow tailoring demands a record allowing a court to meaningfully weigh actual side effects and to compare the chosen medication to feasible alternatives.

Matter of Sawyer [R.G.], 68 AD3d 1734 (4th Dept 2009)

The majority relied on Matter of Sawyer [R.G.] for two propositions: (1) the State’s parens patriae framework for treatment over objection and (2) the operational articulation of the Rivers “narrowly tailored” inquiry in Fourth Department practice. It reinforced the majority’s conclusion that the hearing evidence sufficiently addressed benefits, risks, monitoring, and alternatives.

Matter of Schlee [Clarence E.], 194 AD3d 1365 (4th Dept 2021)

Cited to support the incapacity finding: lack of insight into mental illness and treatment need can demonstrate inability to make a reasoned decision. The majority used Schlee to validate that respondent’s denial of illness and the behavioral consequences of non-medication supported incapacity under Rivers.

Matter of Paris M. v Creedmoor Psychiatric Ctr., 30 AD3d 425 (2d Dept 2006)

Cited to bolster the inference that refusal grounded in denial of illness and failure to appreciate consequences supports incapacity. The majority used it as confirmatory authority consistent with Schlee.

Matter of Dill v Brian S., 221 AD3d 1497 (4th Dept 2023)

Used by the dissent to frame narrow tailoring as an evidentiary, circumstance-specific balancing test. The dissent treated Dill as requiring a record that permits evaluation of (i) best interests, (ii) benefits, (iii) adverse side effects (including those actually experienced), and (iv) less intrusive alternatives—rather than accepting general assurances.

Matter of Michael L., 26 AD3d 381 (2d Dept 2006)

Cited by the dissent to highlight that, in some cases, the absence of medical records in evidence can undercut the sufficiency of proof. Here, the dissent viewed the lack of introduced records as preventing a reliable assessment of side effects and treatment necessity over time.

Matter of Harper v Louis M. [appeal No. 2], 196 AD3d 1086 (4th Dept 2021)

Used by the dissent by contrast (“cf.”) to suggest that evaluation reports from treating/reviewing physicians—when properly introduced—can substantiate narrow tailoring. The dissent emphasized that attachments to the petition are not automatically evidence at the hearing.

Matter of Radcliffe M., 155 AD3d 956 (2d Dept 2017)

The dissent relied on Radcliffe M. for the proposition that reports attached to a petition are not themselves evidence absent proper admission, and for skepticism toward conclusory assertions about benefits outweighing risks—particularly regarding alternatives and dosing.

Matter of Tyrone M., 186 AD3d 604 (2d Dept 2020)

Central to the dissent’s critique: Tyrone M. is cited for requiring an explanation of why a particular antipsychotic is selected over others and for requiring a factual basis for dosage and frequency. The dissent argued this record lacked the comparative analysis and dosing rationale needed to deem the plan narrowly tailored.

Matter of Guttmacher [James M.], 181 AD3d 1313 (4th Dept 2020)

The dissent cited Guttmacher by contrast to suggest that, where a record contains adequate factual grounding, authorization regarding dosing/frequency may be sustained. Here, the dissent found that grounding missing (e.g., blood-level testing pending; no established dosing plan).

Wrobel v Tops Mkts., LLC, 155 AD3d 1591 (4th Dept 2017) and Costanzo v County of Chautauqua, 110 AD3d 1473 (4th Dept 2013)

Though not mental hygiene cases, the dissent invoked these to support a broader evidentiary principle: conclusory expert assertions—untethered to supporting facts—are insufficient. The dissent used them to argue petitioner’s showing on Benadryl benefits/risks and alternative medications was too conclusory.

B. Legal Reasoning

1) Incapacity (Majority and Dissent Agree)

Applying Rivers v Katz, the majority held petitioner proved incapacity by clear and convincing evidence. The proof included diagnosis (schizoaffective disorder, bipolar type), lack of insight, and behavior without medication (hunger strikes, delusional outbursts, verbal/physical aggression). The court treated respondent’s denial of need for medication as demonstrating an inability to appreciate his condition and its consequences, consistent with Matter of Schlee [Clarence E.] and Matter of Paris M. v Creedmoor Psychiatric Ctr..

2) Narrow Tailoring (Point of Division)

Majority: Found the plan narrowly tailored based on the treating psychiatrist’s hearing testimony: the regimen had been used in prior court orders; Abilify Maintena was described as successful in preventing some of respondent’s most challenging behaviors; side effects were identified and monitored (including blood monitoring); and alternatives were authorized. The majority accepted the psychiatrist’s risk-benefit conclusion and his opinion that the plan was the least restrictive efficacious treatment, aligning with Matter of Sawyer [R.G.] and Rivers v Katz.

Dissent: Would hold petitioner failed to meet the clear-and-convincing standard on narrow tailoring because the record did not allow the court to meaningfully determine whether benefits outweighed the side effects respondent actually reported (tremor, sluggishness, high cholesterol, high blood pressure, chest pain, bradycardia), whether Abilify Maintena was justified over other antipsychotics, and what dosing/frequency was warranted. The dissent emphasized:

  • Record problem: medical records and evaluation reports were not introduced; attachments to the petition are not evidence (Matter of Radcliffe M.).
  • Comparative justification: insufficient explanation why Abilify Maintena over other options (Matter of Tyrone M.).
  • Side-effect management: monitoring was described, but not how existing symptoms would be treated or when alternatives would be triggered.
  • Dose/frequency basis: blood-level testing was pending; petitioner had not previously monitored blood levels; the psychiatrist did not identify precise dosing to be used, making the authorized “up to” regimen insufficiently grounded (Matter of Tyrone M.).
  • Conclusions vs facts: assertions about Benadryl and alternatives were conclusory (Wrobel v Tops Mkts., LLC; Costanzo v County of Chautauqua).

C. Impact

Practical takeaway from the majority holding: In the Fourth Department, a treating psychiatrist’s live testimony—covering diagnosis, behavioral deterioration without medication, prior treatment orders, risk/benefit assessment, monitoring, and least-restrictive rationale—may suffice to meet the Rivers narrow-tailoring requirement even without additional medical witnesses and even where the order authorizes a structured regimen plus alternatives.

Countervailing signal from the dissent: The dissent provides a detailed roadmap for challenging (or future courts for scrutinizing) medication-over-objection applications where the evidentiary record does not include admitted medical records/evaluation reports, does not justify why the chosen long-acting injectable is preferable to other antipsychotics for the particular patient, and does not factually support authorized dosing ranges and side-effect protocols. This may influence how petitions are litigated: more robust evidentiary submissions and more granular testimony (especially on dosing rationale and criteria for switching/alternatives) can reduce appellate risk.

Systemic effect: The decision underscores the continuing centrality of Rivers v Katz—capacity plus narrow tailoring—and highlights a recurring tension in these hearings: efficiency and clinical discretion versus the need for a record detailed enough to demonstrate constitutionally adequate tailoring to the patient’s liberty interest.

4. Complex Concepts Simplified

  • Parens patriae: the State’s power to act as guardian for individuals who cannot care for themselves, including authorizing treatment when legal standards are met.
  • Medication over objection: a court order allowing clinicians to administer medication despite a patient’s refusal, subject to constitutional protections.
  • Clear and convincing evidence: a high level of proof—more than “preponderance,” less than “beyond a reasonable doubt”—requiring strong, reliable evidence.
  • Capacity to make a reasoned decision: not whether the patient agrees with doctors, but whether the patient can understand, appreciate, and rationally weigh information about the proposed treatment.
  • “Narrowly tailored” treatment plan: the treatment must be crafted to respect liberty as much as possible while achieving clinical goals—meaning the court must consider benefits, side effects, best interests, and less intrusive alternatives.
  • Least restrictive alternative: among effective options, the one that intrudes least on autonomy and liberty interests.

5. Conclusion

Matter of Walawender v Antonio T. reaffirms the Rivers v Katz framework and, on the majority’s view, demonstrates that detailed treating-psychiatrist testimony can carry petitioner’s burden on both incapacity and narrow tailoring for a multi-year antipsychotic regimen that includes monitoring and authorized alternatives.

The dissent, however, highlights litigation-critical evidentiary vulnerabilities—especially the absence of admitted medical records, insufficient comparative justification for the chosen medication, and lack of factual support for dosing/frequency and side-effect interventions. Going forward, the case is significant both for what it sustains (a testimony-driven showing of narrow tailoring) and for the dissent’s blueprint of what a more rigorous narrow-tailoring record may require.